|
Originally published In Press as doi:10.1074/jbc.M202625200 on May 8, 2002
J. Biol. Chem., Vol. 277, Issue 31, 28127-28134, August 2, 2002
Predominant Nuclear Localization of Mammalian
Target of Rapamycin in Normal and Malignant Cells in
Culture*
Xiongwen
Zhang,
Lili
Shu,
Hajime
Hosoi ,
K. Gopal
Murti, and
Peter J.
Houghton§
From the Department of Molecular Pharmacology, St. Jude Children's
Research Hospital, Memphis, Tennessee 38105-2794
Mammalian target of rapamycin (mTOR) controls
initiation of translation through regulation of ribosomal p70S6 kinase
(S6K1) and eukaryotic translation initiation factor-4E (eIF4E) binding protein (4E-BP). mTOR is considered to be located predominantly in
cytosolic or membrane fractions and may shuttle between the cytoplasm
and nucleus. In most previous studies a single cell line,
E1A-immortalized human embryonic kidney cells (HEK293), has been used.
Here we show that in human malignant cell lines, human fibroblasts, and
murine myoblasts mTOR is predominantly nuclear. In contrast, mTOR is
largely excluded from the nucleus in HEK293 cells. Hybrids between
HEK293 and Rh30 rhabdomyosarcoma cells generated cells co-expressing
markers unique to HEK293 (E1A) and Rh30 (MyoD). mTOR distribution was
mainly nuclear with detectable levels in the cytoplasm. mTOR isolated
from Rh30 nuclei phosphorylated recombinant GST-4E-BP1
(Thr-46) in vitro and thus has kinase activity. We
next investigated the cellular distribution of mTOR substrates 4E-BP,
S6K1, and eIF4E. 4E-BP was exclusively detected in cytoplasmic fractions in all cell lines. S6K1 was localized in the cytoplasm in
colon carcinoma, HEK293 cells, and IMR90 fibroblasts. S6K1 was readily
detected in all cellular fractions derived from rhabdomyosarcoma cells.
eIF4E was detected in all fractions derived from rhabdomyosarcoma cells
but was not detectable in nuclear fractions from colon carcinoma HEK293
or IMR90 cells.
*
This work was supported by United States Public Health
Services Grants CA77776, CA23099, and CA28765 (Cancer Center Support Grant) from NCI, National Institutes of Health; by a grant from Wyeth-Ayerst Laboratories; and by the American Lebanese Syrian Associated Charities.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Pediatrics, Kyoto Prefectural University
of Medicine, Kyoto 602, Japan.
§
To whom correspondence should be addressed: Dept. of Molecular
Pharmacology, St. Jude Children's Research Hospital, Mail Stop 230, 332 N. Lauderdale St., Memphis, TN 38105-2794. Tel.: 901-495-3440; Fax:
901-521-1668; E-mail: peter.houghton@stjude.org.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. R. Hagner, K. Mazan-Mamczarz, B. Dai, S. Corl, X. F. Zhao, and R. B. Gartenhaus
Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction
Blood,
May 28, 2009;
113(22):
5526 - 5535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosner and M. Hengstschlager
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1
Hum. Mol. Genet.,
October 1, 2008;
17(19):
2934 - 2948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Sturgill, A. Cohen, M. Diefenbacher, M. Trautwein, D. E. Martin, and M. N. Hall
TOR1 and TOR2 Have Distinct Locations in Live Cells
Eukaryot. Cell,
October 1, 2008;
7(10):
1819 - 1830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Barquilla, J. L. Crespo, and M. Navarro
Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation
PNAS,
September 23, 2008;
105(38):
14579 - 14584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ma, X. Bai, S. Guo, and Y. Jiang
The Switch I Region of Rheb Is Critical for Its Interaction with FKBP38
J. Biol. Chem.,
September 19, 2008;
283(38):
25963 - 25970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rong, M. Livingstone, R. Sukarieh, E. Petroulakis, A.-C. Gingras, K. Crosby, B. Smith, R. D. Polakiewicz, J. Pelletier, M. A. Ferraiuolo, et al.
Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs
RNA,
July 1, 2008;
14(7):
1318 - 1327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yaba, V. Bianchi, A. Borini, and J. Johnson
A Putative Mitotic Checkpoint Dependent on mTOR Function Controls Cell Proliferation and Survival in Ovarian Granulosa Cells
Reproductive Sciences,
February 1, 2008;
15(2):
128 - 138.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu and X. F. S. Zheng
Endoplasmic Reticulum and Golgi Localization Sequences for Mammalian Target of Rapamycin
Mol. Biol. Cell,
March 1, 2007;
18(3):
1073 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Peponi, E. Drakos, G. Reyes, V. Leventaki, G. Z. Rassidakis, and L. J. Medeiros
Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
Am. J. Pathol.,
December 1, 2006;
169(6):
2171 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. York, D. Lou, and D. J. Noonan
Tuberin Nuclear Localization Can Be Regulated by Phosphorylation of Its Carboxyl Terminus
Mol. Cancer Res.,
November 1, 2006;
4(11):
885 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Panasyuk, I. Nemazanyy, A. Zhyvoloup, M. Bretner, D. W. Litchfield, V. Filonenko, and I. T. Gout
Nuclear Export of S6K1 II Is Regulated by Protein Kinase CK2 Phosphorylation at Ser-17
J. Biol. Chem.,
October 20, 2006;
281(42):
31188 - 31201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Matsushima, N. Harada, N. J. G. Webster, Y. M. Tsutsumi, and Y. Nakaya
Effect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity
J. Biol. Chem.,
October 6, 2006;
281(40):
29719 - 29729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paglin, N.-Y. Lee, C. Nakar, M. Fitzgerald, J. Plotkin, B. Deuel, N. Hackett, M. McMahill, E. Sphicas, N. Lampen, et al.
Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells
Cancer Res.,
December 1, 2005;
65(23):
11061 - 11070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hedhli, M. Pelat, and C. Depre
Protein turnover in cardiac cell growth and survival
Cardiovasc Res,
November 1, 2005;
68(2):
186 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Dames, J. M. Mulet, K. Rathgeb-Szabo, M. N. Hall, and S. Grzesiek
The Solution Structure of the FATC Domain of the Protein Kinase Target of Rapamycin Suggests a Role for Redox-dependent Structural and Cellular Stability
J. Biol. Chem.,
May 27, 2005;
280(21):
20558 - 20564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cao, F. Kambe, L. C. Moeller, S. Refetoff, and H. Seo
Thyroid Hormone Induces Rapid Activation of Akt/Protein Kinase B-Mammalian Target of Rapamycin-p70S6K Cascade through Phosphatidylinositol 3-Kinase in Human Fibroblasts
Mol. Endocrinol.,
January 1, 2005;
19(1):
102 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Fleming, W. Y. Kwong, R. Porter, E. Ursell, I. Fesenko, A. Wilkins, D. J. Miller, A. J. Watkins, and J. J. Eckert
The Embryo and Its Future
Biol Reprod,
October 1, 2004;
71(4):
1046 - 1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huang, L. Shu, J. Easton, F. C. Harwood, G. S. Germain, H. Ichijo, and P. J. Houghton
Inhibition of Mammalian Target of Rapamycin Activates Apoptosis Signal-regulating Kinase 1 Signaling by Suppressing Protein Phosphatase 5 Activity
J. Biol. Chem.,
August 27, 2004;
279(35):
36490 - 36496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zohlnhofer, T. G. Nuhrenberg, F.-J. Neumann, T. Richter, A. E. May, R. Schmidt, K. Denker, M. A. Clauss, A. Schomig, and P. A. Baeuerle
Rapamycin Effects Transcriptional Programs in Smooth Muscle Cells Controlling Proliferative and Inflammatory Properties
Mol. Pharmacol.,
April 1, 2004;
65(4):
880 - 889.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. M. Drenan, X. Liu, P. G. Bertram, and X. F. S. Zheng
FKBP12-Rapamycin-associated Protein or Mammalian Target of Rapamycin (FRAP/mTOR) Localization in the Endoplasmic Reticulum and the Golgi Apparatus
J. Biol. Chem.,
January 2, 2004;
279(1):
772 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Harris and J. C. Lawrence Jr.
TOR Signaling
Sci. Signal.,
December 9, 2003;
2003(212):
re15 - re15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. M. Tirado, S. Mateo-Lozano, S. Sanders, L. E. Dettin, and V. Notario
The PCPH Oncoprotein Antagonizes the Proapoptotic Role of the Mammalian Target of Rapamycin in the Response of Normal Fibroblasts to Ionizing Radiation
Cancer Res.,
October 1, 2003;
63(19):
6290 - 6298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Kenerson, L. D. Aicher, L. D. True, and R. S. Yeung
Activated Mammalian Target of Rapamycin Pathway in the Pathogenesis of Tuberous Sclerosis Complex Renal Tumors
Cancer Res.,
October 15, 2002;
62(20):
5645 - 5650.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|